This is an EpiPen. Its a manoeuvre that inserts you with adrenalineif youre having a possibly deadly allergic reaction. If “youve had” severe allergies, you basicallyneed it. And if “youre living in” the UK, an EpiPen willcost you the equivalent of 38 US dollars. But if you live in the US, itll cost you $300. And its not only the EpiPen. Lets look at five of the top selling prescriptiondrugs in the world. Advair, a brand-name asthma inhaler: moreexpensive in the US. Lantus, a type of Insulin: more expensivein the US. Sovaldi for hepatitis C? Yup. Expenditures more in the US.Humira for arthritis. Crestor for cholesterol: more costly inthe US. So heres an unsurprising plot: Americans deplete more on prescription drugsthan anyone else in the world. Why? The first thing you have to understand isthat in the US, stimulants get to patients differently than almost everywhere else. Let look at that popular hepatitis C stimulant, Sovaldi. In 2014 Sovaldi became the first narcotic to completelycure hepatitis C. Heres how it got to market in, for example, the UK. First a government agency had to decide thatSovaldi was safe and that it actually made. Then it was evaluated by a regulatory agencyto see if was worthwhile: Are there too many side effects? Is there already a same stimulant? Is there a cheaper alternative? Sovaldi was deemed worthwhile.Next, they negotiated the cost. In the UK, the government buys the stock ofmedicine for the country. That means theyre generally able to get alower rate, kind of like a volume reject. Which holds prescription drugs cheaper forUK citizens. In almost every developed country besidesthe US, this is what the system looks like: Safety evaluation, assessment of whether thecountry needs it, rate discussions, sell off patients. Now makes look at the system in the US.First, the drug is evaluated for safety, but thats it. If its safe, they can sell it, mission of tale. Medicines are sold by the drug companies to patients, often through insurance. And since the US system makes them sell itfor any price, Gilead, the company that impels Sovaldi, blamed Americans more for it. When it firstly came to market, the entire treatmentcost $84,000 in the US. In the UK? Just about $58,000 US dollars. Thats still a lot of money, but itsa full 30% little. So it seems like the UK has the better systemright? Well, its complicated. These photos are from declarations in the US againstthe high price of EpiPens. And the latter are photos from declarations in theUK, over the lack of access to a cystic fibrosis drug announced Orkambi. Thats because when theres a committeethat shall determine whether a brand-new stimulant is worthwhile sometimes they say no. And when they negotiate the prices, sometimesthey dont reaching agreement and touched a standoff. Thats whats happening with Orkambi.Both arrangements require trade offs. Regulated drug business tend to form drugsmore inexpensive, but some narcotics are perfectly inaccessible. And while the US has more doses technicallyavailable, theyre often too expensive to actually afford. Americans without policy are the most likelyto skip medication because of the cost. Even Americans with assurance, are second. But the commonality between these two systems is the drug business. Developing new medication concoctions isnt cheapand theyre for-profit occupations. If Gilead didnt think that researchingand developing a hepatitis C cure, would spawn them money in the end, they are likely not have. And with these adjusted business saving costsdown, the only place the remedy companies can really make their money is, you guessed it, the US. Americans are essentially subsidizing thecost of drugs for the rest of the world. In other utterances, a big part of why prescriptiondrugs are more expensive in the US is because theyre cheaper everywhere else. If you’d like to continue exploring the importance of easier access to medicine and vaccines, then I most recommend a documentary announced “Viruses: Destruction and Creation, ” available now on CuriosityStream.CuriosityStream is a subscription service that offers more than 2,400 documentaries and non-fiction entitles, from some of the world’s best filmmakers. You can get unlimited access starting at $2.99 a month and because you’re a Vox fan, the first 31 dates are free if you sign on at curiositystream.com/ vox and use the promo system “VOX”. CuriosityStream doesn’t directly impact our editorial, but their brace prepares videos like this one possible. So go check them out ..
